Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non‐reconstructable peripheral arterial disease

Published on Oct 5, 2011in Cochrane Database of Systematic Reviews7.89
· DOI :10.1002/14651858.CD009366.PUB2
Indrani Sen9
Estimated H-index: 9
,
Sunil Agarwal10
Estimated H-index: 10
+ 1 AuthorsRachel Forster8
Estimated H-index: 8
(Edin.: University of Edinburgh)
Sources
Abstract
BACKGROUND:Peripheral arterial disease (PAD) is a common circulatory problem that can lead to reduced blood flow to the limbs, which may result in critical limb ischaemia (CLI), a painful manifestation that occurs when a person is at rest. The mainstay of treatment for CLI is surgical or endovascular repair. However, when these means of treatment are not suitable, due to anatomical reasons or comorbidities, treatment for pain is limited. Lumbar sympathectomy and prostanoids have both been shown to reduce pain from CLI in people who suffer from non-reconstructable PAD, but there is currently insufficient evidence to determine if one treatment is superior. Due to the severity of the rest pain caused by CLI, and its impact on quality of life, it is important that people are receiving the best pain relief treatment available, therefore interest in this area of research is high. OBJECTIVES:To compare the efficacy of lumbar sympathectomy with prostanoid infusion in improving symptoms and function and avoiding amputation in people with critical limb ischaemia (CLI) due to non-reconstructable peripheral arterial disease (PAD). SEARCH METHODS:The Cochrane Vascular Information Specialist (CIS) searched the Specialised Register (last searched 29 March 2017) and CENTRAL (2017, Issue 2). The CIS also searched clinical trials databases for ongoing or unpublished studies. SELECTION CRITERIA:Randomised controlled trials (RCTs), with parallel treatment groups, that compared lumbar sympathectomy (surgical or chemical) with prostanoids (any type and dosage) in people with CLI due to non-reconstructable PAD. DATA COLLECTION AND ANALYSIS:Three review authors independently selected trials, extracted data and assessed risk of bias. Any disagreements were resolved by discussion. We performed fixed-effect model meta-analyses, when there was no overt sign of heterogeneity, with risk ratios (RRs) and 95% confidence intervals (CIs). We graded the quality of evidence according to GRADE. MAIN RESULTS:We included a single study in this review comparing lumbar sympathectomy with prostanoids for the treatment of CLI in people with non-reconstructable PAD. The single study included 200 participants with Buerger's disease, a form of PAD, 100 in each treatment group, but only 162 were actually included in the analyses. The study compared an open surgical technique for lumbar sympathectomy with the prostanoid, iloprost, and followed participants for 24 weeks.Risk of bias was low for most evaluated domains. Due to the nature of the treatment, blinding of the participants and those providing the treatment would be impossible as a surgical procedure was compared with intravenous injections. It was not mentioned if blinded assessors evaluated the study outcomes, therefore, we judged subjective outcomes (i.e. pain reduction) to be at unclear risk of detection bias and objective outcomes (i.e. ulcer healing, amputation and mortality) at low risk of detection bias. We also rated the risk of attrition bias as unclear; 38 out of 200 (19%) participants were not included in the analysis without clear explanation (16 of 100 in the iloprost arm and 22 of 100 in the sympathectomy arm). The quality of evidence was low due to serious imprecision because the study numbers were low and there was only one study included.The single included study reported on the outcome of complete healing without pain or major amputation, which fell under three separate outcomes for our review: relief of rest pain, complete ulcer healing and avoidance of major amputation. We chose to keep the outcome as a singularly reported outcome in order to not introduce bias into the outcomes, which may have been the case if reported separately. The limited evidence suggests participants who received prostaglandins had improved complete ulcer healing without rest pain or major amputation when compared with those who received lumbar sympathectomy (RR 1.63, 95% CI 1.30 to 2.05), but as it was the only included study, we rated the data as low-quality and could not draw any overall conclusions. The study authors stated that more participants who received prostaglandins reported adverse effects, such as headache, flushing, nausea and abdominal discomfort, but only one participant experienced severe enough adverse effects to drop out. Five participants who underwent lumbar sympathectomy reported minor wound infection (low-quality evidence). There was no reported mortality in either of the treatment groups (low-quality evidence).The included study did not report on claudication distances, quality of life or functional status, ankle brachial pressure index (ABPI), tissue oxygenation or toe pressures, or progression to minor amputation, complications or provide any cost-effectiveness data. AUTHORS' CONCLUSIONS:Low-quality evidence from a single study in a select group of participants (people with Buerger's disease) suggests that prostaglandins are superior to open surgical lumbar sympathectomy for complete ulcer healing without rest pain or major amputation, but possibly incur more adverse effects. Further studies are needed to better understand if prostaglandins truly are more efficacious than open surgical lumbar sympathectomy and if there are any concerns with adverse effects. It would be of great importance for future studies to include other forms of PAD (as Buerger's disease is a select type of PAD), other methods of sympathectomy as well as data on quality of life, complications and cost-effectiveness.
📖 Papers frequently viewed together
2005
3 Authors (Aliu Sanni, ..., Joel Dunning)
1 Citations
5 Citations
1 Author (E. Minar)
37 Citations
References21
Newest
#1Jonathan J Deeks (University of Birmingham)H-Index: 116
#2Julian P T HigginsH-Index: 135
Last. Douglas G. Altman (University of Oxford)H-Index: 268
view all 3 authors...
1,058 CitationsSource
#1Alessandro LiberatiH-Index: 50
#2Douglas G. Altman (University of Oxford)H-Index: 268
Last. David Moher (Ottawa Hospital Research Institute)H-Index: 129
view all 10 authors...
Systematic reviews and meta-analyses are essential to summarize evidence relating to efficacy and safety of health care interventions accurately and reliably. The clarity and transparency of these reports, however, is not optimal. Poor reporting of systematic reviews diminishes their value to clinicians, policy makers, and other users. Since the development of the QUOROM (QUality Of Reporting Of Meta-analysis) Statement—a reporting guideline published in 1999—there have been several conceptual, ...
20.3k CitationsSource
#1Ezio FagliaH-Index: 29
#2Giacomo ClericiH-Index: 18
Last. Alberto Morabito (University of Milan)H-Index: 79
view all 11 authors...
Objective- To evaluate the long-term prognosis of critical limb ischemia (CLI) in diabetic patients. Research design and methods- 564 consecutive diabetic patients were hospitalized for CLI from January 1999 to December 2003; 554 were followed until December 2007. Results- The mean follow up was 5.93 ± 1.28 years. Peripheral angioplasty (PTA) was performed in 420 (74.5%) and bypass graft (BPG) in 117 (20.6%) patients. Neither PTA nor BPG were possible in 27 (4.9%) patients. Major amputations wer...
151 CitationsSource
#1Vincent L. RoweH-Index: 24
#2William H. K. LeeH-Index: 27
Last. David A. Etzioni (SC: University of Southern California)H-Index: 36
view all 4 authors...
Objective Endovascular procedures are increasingly used in the treatment of peripheral arterial disease (PAD). Whether this new procedural approach translates to clinical outcomes equivalent or superior to open surgical revascularization is a subject of debate. We sought to analyze population-based rates of major amputations for PAD during a time period in which the use of endovascular surgical procedures increased dramatically. Methods We used the 1996-2005 Nationwide Inpatient Sample (NIS) to ...
165 CitationsSource
#1Jonathan J DeeksH-Index: 116
#2Julian P T HigginsH-Index: 135
Last. Douglas G. AltmanH-Index: 268
view all 3 authors...
1,629 Citations
#1Ph. Gabriel StegH-Index: 40
#2Deepak L. BhattH-Index: 167
Last. Shinya GotoH-Index: 76
view all 12 authors...
ContextFew data document current cardiovascular (CV) event rates in stable patients with atherothrombosis in a community setting. Differential event rates for patients with documented coronary artery disease (CAD), cerebrovascular disease (CVD), or peripheral arterial disease (PAD) or those at risk of these diseases have not been previously evaluated in a single international cohort.ObjectiveTo establish contemporary, international, 1-year CV event rates in outpatients with established arterial ...
1,025 CitationsSource
#1A.D. LeeH-Index: 5
#2Sunil AgarwalH-Index: 10
Last. David SadhuH-Index: 4
view all 3 authors...
Background Severely symptomatic arterial insufficiency of an upper limb not suitable for revascularization is a difficult condition to manage. Thoracoscopic sympathectomy (TS) can be an effective procedure in this setting.
15 CitationsSource
#1Ahmet Kürşat Bozkurt (Istanbul University)H-Index: 9
#2Cengiz KöksalH-Index: 9
Last. A G SayinH-Index: 1
view all 15 authors...
Aim. The aim of this study was to compare the effects of iloprost and lumbar sympathectomy (LS) in the treatment of Buerger's disease. Methods. Two hundred patients with rest pain and/or ischemic ulcers were randomized to undergo LS or 28-day intravenous treatment of iloprost. The primary endpoint was complete healing without pain or major amputation at 4 and 24 weeks. The secondary endpoints were analgesic requirement, reduction in the ulcer size, 50% reduction of the ulcer, and shift in the mo...
41 Citations
#1Stefano PieriH-Index: 8
#2Paolo AgrestiH-Index: 6
Last. Ricci GH-Index: 1
view all 6 authors...
PURPOSE: Lumbar sympathectomy is a complementary therapeutic option for patients with severe peripheral vascular occlusive disease presenting rest pain or gangrene and not eligible for surgical revascularisation. Traditional surgical sympathectomy was widely used in the past. However, due to its invasive character, it has increasingly been replaced by percutaneous techniques and, in some recent cases, by laparoscopic procedures. Percutaneous lumbar sympathectomy is a safe, cost-effective and wid...
12 Citations
: Patients with threatening ischemia of the lower extremities constitute a steadily increasing patient population owing to the increasing age of the general population and the growing incidence of diabetes. The goals of treatment for patients with critical limb ischemia (CLI) are pain control, wound healing, limb salvage, improvement of quality of life and reduction of overall cardiovascular risk. A high proportion of patients with CLI have coexisting diseases, mainly cardiovascular and renal di...
12 CitationsSource
Cited By4
Newest
Source
Die pAVK stellt eine der haufigsten Erkrankungen vor allem in westlichen Industrienationen dar. In den letzten Jahren hat sich der Trend von der offenen chirurgischen zur endovaskularen Revaskularisation weiter fortgesetzt. Aufgrund der hohen Erfolgs- und geringen Komplikationsrate stellen Interventionen in den uberwiegenden Fallen die Methode der Wahl dar. Eine Hauptlimitation ist das Auftreten von Restenosen nach Interventionen. Ein deutlicher Fortschritt konnte hierbei durch den Einsatz medik...
Source
#1Veena K.L. Karanth (KMC: Kasturba Medical College, Manipal)H-Index: 2
#2Tulasi Kota Karanth (KMC: Kasturba Medical College, Manipal)H-Index: 2
Last. Laxminarayan Karanth (Manipal University)H-Index: 7
view all 3 authors...
BACKGROUND: Critical lower limb ischaemia (CLI) is a manifestation of peripheral arterial disease (PAD) that is seen in patients with typical chronic ischaemic rest pain or patients with ischaemic skin lesions - ulcers or gangrene - for longer than 2 weeks. Critical lower limb ischaemia is the most severe form of PAD, and interventions to improve arterial perfusion become necessary. Although surgical bypass has been the gold standard for revascularisation, the extent or the site of disease may b...
8 CitationsSource
#1Valeria Vietto (Cochrane Collaboration)H-Index: 7
#2Juan Va FrancoH-Index: 7
Last. Agustín Ciapponi (Cochrane Collaboration)H-Index: 34
view all 6 authors...
Background Peripheral arterial occlusive disease (PAOD) is a common cause of morbidity and mortality due to cardiovascular diseases in the general population. While numerous treatments have been adopted for different disease stages, there is no option other than amputation for patients presenting with critical limb ischaemia (CLI), unsuitable for rescue or reconstructive intervention. Objectives To determine the effectiveness and safety of prostanoids in patients presenting with CLI. Search meth...
76 CitationsSource